MSN Labs begins COVID drug Molnupiravir phase III trial Ruchika Sharma26 May 2021 12:23 PM ISTMolnupiravir is an experimental drug having antiviral properties and is currently under clinical-stage study for COVID treatment.
Bharat Biotech American partner submits Covaxin Master File to USFDA Ruchika Sharma26 May 2021 11:37 AM ISTIn an investor presentation, Ocugen said it is expecting the vaccine to be rolled out in the US during the second half of the current year.
Prone positioning beneficial for severe ARDS in postpartum COVID-19 patients: BMJ case report Dr Nirali Kapoor26 May 2021 9:45 AM ISTPregnant women is a population of particular concern given the medical experience during prior SARS-CoV-1 and Middle East respiratory syndrome...
Dentists have lower COVID-19 infection rates compared to other health professionals: Study Hina Zahid26 May 2021 9:00 AM ISTCHICAGO - More than a year after COVID-19 appeared in the U.S., dentists continue to have a lower infection rate than other front-line health...
FLCCC releases COVID-19 Hospital Treatment Protocol Hina Zahid25 May 2021 10:00 PM IST-New York, New York - The Frontline COVID-19 Critical Care Alliance (FLCCC) announces that their highly effective, combination therapy treatment...
Bal Pharma launches Favipiravir under brand name BALflu Ruchika Sharma25 May 2021 1:11 PM ISTBALflu has the efficacy to clear the virus faster by 28.7% and is marketed at a very affordable price of Rs. 85 per tablet, said Managing Director...
Panacea Biotec, RDIF launch Sputnik V production in India Ruchika Sharma25 May 2021 12:00 PM ISTNew Delhi: The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Panacea Biotec have recently announced the launch of...
WHO seeks more information from Bharat Biotech for Covaxin emergency use listing Ruchika Sharma25 May 2021 11:00 AM ISTNew York/Geneva: The World Health Organisation (WHO) has said "more information" is "required" from Bharat Biotech, which is seeking emergency use...
Cadila Healthcare to produce up to 30 million COVID vaccines per month Ruchika Sharma25 May 2021 10:00 AM ISTZyCoV-D is a DNA plasmid vaccine, which uses a portion of the genetic code - DNA or RNA - in the virus to stimulate an immune response.
Pfizer, Govt in talks to bring COVID vaccine in India Ruchika Sharma25 May 2021 9:00 AM ISTNew Delhi: To bring Pfizer-BioNTech Covid-19 vaccine for use in India, discussions are underway between the Government of India (GOI) and Pfizer...
Can breastfeeding be continued if mother is positive for COVID-19? dr anusha24 May 2021 5:30 PM ISTBreastfeeding is the cornerstone of infant and young child survival, nutrition and development and maternal health. However, concerns have been raised...
First: Roche- CIPLA Antibody Cocktail of Casirivimab and Imdevimab for mild to moderate COVID-19 now available in India Ruchika Sharma24 May 2021 2:44 PM ISTThe antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in...
